tirzepatide in the news FDA says weight-loss drug shortage is over Tirzepatide is NO longer in

Su K, Xu J, Hu S, Ye H, Xie L, Ouyang S (2024) Advances in small-molecule insulin secretagogues for diabetes treatment

Chemical Properties Source: NCBI PubChem public domain data 2D structure diagram from NCBI PubChem

Under the deal, the drug makers will expand access to their popular obesity medications, such as Ozempic, Wegovy and Zepbound, by offering them direct-to-consumers on TrumpRx, the government website expected to launch next year

Weight Loss for Winter: Achieving Your Ideal Body for the New Year With approximately two-thirds of US adults overweight and the increasing number of overweight children, weight loss is a concern that touches everyone, one way or another